Abstract
The first contrast agent for magnetic resonance imaging had been available for clinical use in the United States for just over 1 year. It has been widely adopted for a variety of indications with apparent safety. Several other agents are in clinical trials and are reviewed here.

This publication has 1 reference indexed in Scilit: